Reimbursement of health technologies for blood glucose and diabetes control
The exceptional regime of health technology reimbursement for self-monitoring of blood glucose and control of diabetes mellitus has been approved, under Administrative Ruling no. 170/2025/1 of 10 April.
The Administrative Ruling comes into force on 9 August 2025 and its implementation will be monitored by INFARMED, in conjunction with SPMS.
Did you find this article useful?
Download PDF